疑似无菌性髋关节翻修术中意外阳性培养的患病率与结局
本研究回顾2006至2019年同一机构2288例全髋关节翻修术,纳入1196例疑似无菌性翻修且术中送培养的病例。意外阳性培养(UPC)占9.2%,2年和5年无感染假体生存率分别为93.1%和86.8%,由同一微生物所致PJI的5年无失败生存率为94.3%。
要点
- 疑似无菌性翻修THA中UPC患病率为9.2%,无感染假体生存率较好。
- ≥2个UPC较单个UPC更易发生同一微生物感染相关失败(p=0.024)。
- adverse metal reaction翻修是后续感染相关失败的危险因素(HR=14.49)。
核心结论
- 疑似无菌性翻修THA中UPC患病率为9.2%,无感染假体生存率令人鼓舞。
- 由UPC同一微生物所致PJI的无失败生存率极佳。
- 单个UPC且未用抗生素者无同一微生物所致PJI,提示无其他感染征象时单个UPC不需抗生素治疗。
研究设计与样本
- 回顾性队列研究,复习同一机构2006至2019年全部THA翻修2288例。
- 纳入疑似无菌性翻修THA且术中送培养者1196例。
- 对UPC病例行Kaplan-Meier分析和Cox回归分析。
- 证据等级为治疗性IV级。
主要发现
- UPC占1196例疑似无菌性THA翻修的9.2%(110例)。
- 整个UPC队列2年和5年无感染假体生存率分别为93.1%(95%CI=90.5%至95.7%)和86.8%(95%CI=82.9%至90.7%)。
- 以UPC同一微生物感染失败为终点的2年和5年无感染生存率分别为95.8%(95%CI=93.7%至97.9%)和94.3%(95%CI=91.7%至96.9%)。
- ≥2个UPC者发生同一微生物感染相关失败的可能性高于单个UPC者(p=0.024)。
- adverse metal reaction翻修是后续感染相关失败的危险因素(HR=14.49,95%CI=2.69至78.04)。
关键数值与推荐
- UPC患病率9.2%(110/1196例疑似无菌性THA翻修)。
- 2年和5年无感染假体生存率93.1%和86.8%。
- 同一微生物感染失败为终点的2年和5年无感染生存率95.8%和94.3%。
- ≥2个UPC与同一微生物感染相关失败相关(p=0.024)。
- adverse metal reaction翻修HR=14.49(95%CI=2.69至78.04)。
临床怎么用
- 疑似无菌性翻修THA术中应送培养以识别UPC。
- 单个UPC且无其他感染征象时可不使用抗生素治疗。
- 多个UPC或 adverse metal reaction翻修者需警惕后续同一微生物PJI。
局限性
- 本研究为同一机构回顾性分析,证据等级为治疗性IV级。
- 原文未报告UPC具体微生物构成及抗生素使用方案的详细数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence and outcomes of unexpected positive cultures (UPCs) of specimens taken during presumed aseptic revision total hip arthroplasty (THA) are unclear. The purpose of this study was to determine the prevalence of UPC and infection-free implant survival in this patient population. Secondary aims included identifying factors associated with subsequent infection-related failure in patients with UPC. METHODS: We reviewed all THA revisions (n = 2,288) performed at our institution from 2006 to 2019. Presumed aseptic revision THAs with intraoperative culture(s) were eligible (n = 1,196), and those with UPC were included in a Kaplan-Meier analysis to determine the infection-free implant survival and in Cox regression analysis to identify factors associated with infection-related failure. RESULTS: UPC(s) were documented for 9.2% (110) of 1,196 aseptic THA revisions. The 2- and 5-year infection-free implant survival in the entire UPC cohort was 93.1% (95% confidence interval [CI] = 90.5% to 95.7%) and 86.8% (95% CI = 82.9% to 90.7%), respectively. The 2- and 5-year infection-free survival with failure due to infection with the same microorganism as identified in the UPC as the end point was 95.8% (95% CI = 93.7% to 97.9%) and 94.3% (95% CI = 91.7% to 96.9%), respectively. Subsequent infection-related failures caused by the same microorganism as identified in the UPC were more likely to occur after revisions with ≥2 UPCs than after those with 1 UPC (p = 0.024). Revision due to adverse metal reaction was a risk factor for subsequent infection-related failure (hazard ratio [HR] = 14.49, 95% CI = 2.69 to 78.04). Patients with a single UPC who were not treated with antibiotics had no subsequent periprosthetic joint infections (PJIs) caused by the same microorganism as identified in the UPC. CONCLUSIONS: The prevalence of UPC was 9.2%, and the infection-free implant survival in patients with UPC is encouraging. Implant survival free of PJI caused by the same microorganism as identified in the UPC was excellent. Aseptic revision for adverse metal reaction was a risk factor for subsequent PJI in patients with UPC. No patient with a single UPC who was not treated with antibiotics developed PJI caused by the UPC-identified microorganism, suggesting that in the absence of other signs of infection a single UPC does not warrant antibiotic treatment. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Neufeld ME, Lanting BA, Shehata M, et al. Prevalence and Outcomes of Unexpected Positive Intraoperative Cultures in Presumed Aseptic Revision Hip Arthroplasty. J Bone Joint Surg Am. 2021. PMID: 33974575. doi:10.2106/JBJS.20.01559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。